How The U.S. Response To Ebola Shows Failures On Lessons From COVID-19

The United States is repeating the same catastrophic mistakes in its response to the Ebola virus that it made during the COVID-19 pandemic, warns a frontline doctor. A reactive, underfunded approach is squandering hard-won lessons from the deadliest health crisis in a century.
A physician on the frontlines of the current U.S. Ebola response has publicly broken down how Washington is failing to learn from COVID-19. The doctor, who requested anonymity due to political sensitivities, argues that the U.S. is once again prioritizing political optics over science — a pattern that cost tens of thousands of lives in 2020. This time, the stakes are equally high: the 2026 Ebola outbreak, which began in Uganda last November, has already spread to three U.S. states.
The COVID-19 pandemic was supposed to be a turning point. Billions of dollars were poured into the CDC, NIH, and state health departments. Protocols for early testing, genomic surveillance, and rapid contact tracing were rewritten. Yet when Ebola landed on American soil in April 2026, many of those same systems proved unready. Testing kits were slow to deploy, travel restrictions were imposed only after community spread was confirmed, and public messaging was muddled by conflicting guidance from the White House and local officials.
According to the doctor's analysis, published in a recent op-ed, three specific failures stand out. First, the U.S. Strategic National Stockpile had insufficient personal protective equipment specifically rated for Ebola-level biohazards — a direct echo of the N95 mask shortage in 2020. Second, the CDC delayed implementing airport screening in seven major hubs for three weeks after the first domestic case, allowing undetected spread. Third, communication campaigns were launched without a unified spokesperson, leading to confusion over quarantine rules and symptom checklists. As of June 8, 2026, the tally stands at 342 confirmed cases and 19 deaths in the U.S., with hotspots in Texas, New York, and Florida.
The doctor drew sharp parallels to the early days of COVID-19: the same hubris about being prepared, the same reliance on reactive travel bans, and the same broken trust between federal agencies and the public. "We knew that Ebola could come here. We had the blueprints. But someone forgot to build the building," the doctor wrote. The critique aligns with internal CDC memos leaked last week, which showed that funding for a proposed Ebola rapid-response unit was diverted to other programs in 2025.
The broader implications are dire. Infectious disease experts warn that each failure to contain a novel pathogen erodes public trust further, making the next outbreak even harder to manage. If the U.S. cannot apply the lessons of COVID-19 to a well-understood virus like Ebola, faith in the public health system may collapse entirely. The World Health Organization has already downgraded the U.S. pandemic preparedness ranking from first to ninth globally.
What happens next depends on whether the U.S. can pivot from reaction to prevention. Congress is now considering a $12 billion emergency funding bill, but partisan bickering has stalled it for weeks. The CDC director is expected to testify next Thursday. Meanwhile, the clock is ticking. Every day without proactive measures — widespread testing, public education, and contact tracing — the virus gains ground. The world is watching to see if America has finally learned its lesson or is condemned to repeat history.